Paper33692201
Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection.
Jacob-Dolan C and 8 others. J Virol, 2021. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection. Papers, record 33692201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33692201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques Following SARS-CoV-2 Vaccination and Infection.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| F32 AI152296 | NIAID NIH HHS | United States | F32AI152296 | PubMed and NIH | NIH RePORTER |
| UM1 AI126603 | NIAID NIH HHS | United States | UM1AI126603 | PubMed and NIH | NIH RePORTER |
| U01 CA260476 | NCI NIH HHS | United States | U01CA260476 | PubMed | NIH RePORTER |
| R01 AI146779 | NIAID NIH HHS | United States | R01AI146779 | PubMed and NIH | NIH RePORTER |
| UM1 AI124377 | NIAID NIH HHS | United States | UM1AI124377 | PubMed and NIH | NIH RePORTER |
| U19 AI128751 | NIAID NIH HHS | United States | U19AI128751 | PubMed and NIH | NIH RePORTER |
| R01 AI129797 | NIAID NIH HHS | United States | R01AI129797 | PubMed and NIH | NIH RePORTER |
| U19 AI142759 | NIAID NIH HHS | United States | U19AI142759 | PubMed and NIH | NIH RePORTER |
| R01 OD024917 | NIH HHS | United States | R01OD024917 | PubMed and NIH | NIH RePORTER |
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32015507 | A pneumonia outbreak associated with a new coronavirus of probable bat origin. | Nature | 2020 | https://conductscience.org/library/papers/32015507 | PubMed |
| 2 | 33159009 | Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. | Science | 2020 | https://conductscience.org/library/papers/33159009 | PubMed |
| 3 | 33306989 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. | Lancet | 2021 | https://conductscience.org/library/papers/33306989 | PubMed |
| 4 | 32415260 | Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. | Cell Mol Immunol | 2020 | https://conductscience.org/library/papers/32415260 | PubMed |
| 5 | 32473127 | Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. | Cell | 2020 | https://conductscience.org/library/papers/32473127 | PubMed |
| 6 | 32284615 | The proximal origin of SARS-CoV-2. | Nat Med | 2020 | https://conductscience.org/library/papers/32284615 | PubMed |
| 7 | 32994364 | Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. | Science | 2020 | https://conductscience.org/library/papers/32994364 | PubMed |
| 8 | 32866963 | Human germinal centres engage memory and naive B cells after influenza vaccination. | Nature | 2020 | https://conductscience.org/library/papers/32866963 | PubMed |
| 9 | 33276369 | Correlates of protection against SARS-CoV-2 in rhesus macaques. | Nature | 2021 | https://conductscience.org/library/papers/33276369 | PubMed |
| 10 | 33378609 | Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33378609 | PubMed |
| 11 | 26976607 | SARS-like WIV1-CoV poised for human emergence. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/26976607 | PubMed |
| 12 | 32731257 | Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques. | Nature | 2020 | https://conductscience.org/library/papers/32731257 | PubMed |
| 13 | 32884153 | Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters. | Nat Med | 2020 | https://conductscience.org/library/papers/32884153 | PubMed |
| 14 | 32267220 | Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients. | Emerg Infect Dis | 2020 | https://conductscience.org/library/papers/32267220 | PubMed |
| 15 | 32561270 | Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation. | Immunity | 2020 | https://conductscience.org/library/papers/32561270 | PubMed |
| 16 | 32645326 | Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies. | Cell | 2020 | https://conductscience.org/library/papers/32645326 | PubMed |
| 17 | 24040960 | First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood. | BMC Infect Dis | 2013 | https://conductscience.org/library/papers/24040960 | PubMed |
| 18 | 33301246 | Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. | N Engl J Med | 2020 | https://conductscience.org/library/papers/33301246 | PubMed |
| 19 | 32015508 | A new coronavirus associated with human respiratory disease in China. | Nature | 2020 | https://conductscience.org/library/papers/32015508 | PubMed |
| 20 | 32155444 | Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. | Cell | 2020 | https://conductscience.org/library/papers/32155444 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42554640 | Plasma concentrations of nirmatrelvir and molnupiravir required for inhibition of SARS-CoV-2 replication differ between rhesus macaques and humans. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42554640 | PubMed |
| 42094062 | Humoral Immune Correlates Analysis of Four Vaccines Against SARS-CoV-2 in Rhesus Macaques. | Res Sq | 2026 | https://conductscience.org/library/papers/42094062 | PubMed |
| 41295541 | Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41295541 | PubMed |
| 41123344 | Development of a cross-protective common cold coronavirus vaccine. | J Virol | 2025 | https://conductscience.org/library/papers/41123344 | PubMed |
| 40266143 | SARS-CoV-2 mRNA Vaccines Induce Cross-Reactive Antibodies to NL63 Coronavirus but Do Not Boost Pre-Existing Immunity Anti-NL63 Antibody Responses. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40266143 | PubMed |
| 39165724 | Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment. | Pathog Immun | 2024 | https://conductscience.org/library/papers/39165724 | PubMed |
| 38894519 | Immunobiology of COVID-19: Mechanistic and therapeutic insights from animal models. | Zool Res | 2024 | https://conductscience.org/library/papers/38894519 | PubMed |
| 38655202 | B cell somatic hypermutation following COVID-19 vaccination with Ad26.COV2.S. | iScience | 2024 | https://conductscience.org/library/papers/38655202 | PubMed |
| 38566610 | High Frequency of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Sensitive Nucleocapsid Assays. | J Infect Dis | 2024 | https://conductscience.org/library/papers/38566610 | PubMed |
| 37884534 | FHL1 promotes chikungunya and o'nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design. | Nat Commun | 2023 | https://conductscience.org/library/papers/37884534 | PubMed |
| 37242383 | Unravelling Antigenic Cross-Reactions toward the World of Coronaviruses: Extent of the Stability of Shared Epitopes and SARS-CoV-2 Anti-Spike Cross-Neutralizing Antibodies. | Pathogens | 2023 | https://conductscience.org/library/papers/37242383 | PubMed |
| 37029141 | Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques. | Nat Commun | 2023 | https://conductscience.org/library/papers/37029141 | PubMed |
| 36823160 | Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques. | NPJ Vaccines | 2023 | https://conductscience.org/library/papers/36823160 | PubMed |
| 36749755 | Arrayed Imaging Reflectometry monitoring of anti-viral antibody production throughout vaccination and breakthrough Covid-19. | PLoS One | 2023 | https://conductscience.org/library/papers/36749755 | PubMed |
| 36417525 | Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN. | Sci Adv | 2022 | https://conductscience.org/library/papers/36417525 | PubMed |
| 35947380 | Durability of Heterologous and Homologous COVID-19 Vaccine Boosts. | JAMA Netw Open | 2022 | https://conductscience.org/library/papers/35947380 | PubMed |
| 35746653 | Vaccination with BNT162b2 and ChAdOx1 nCoV-19 Induces Cross-Reactive Anti-RBD IgG against SARS-CoV-2 Variants including Omicron. | Viruses | 2022 | https://conductscience.org/library/papers/35746653 | PubMed |
| 35427477 | Vaccine protection against the SARS-CoV-2 Omicron variant in macaques. | Cell | 2022 | https://conductscience.org/library/papers/35427477 | PubMed |
| 35197477 | Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice. | NPJ Vaccines | 2022 | https://conductscience.org/library/papers/35197477 | PubMed |
| 35191769 | A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/35191769 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| DPP4 | 1803 | PubTator's text mining | https://conductscience.org/library/genes/1803 | NCBI Gene |
| VTN | 7448 | PubTator's text mining | https://conductscience.org/library/genes/7448 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33692201
GET https://conductscience.org/api/papers/v1/33692201/references?page=2